These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26661780)

  • 21. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model.
    Boustanshenas M; Bakhshi B; Ghorbani M
    J Appl Microbiol; 2013 Feb; 114(2):509-15. PubMed ID: 23082752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of Chicken Egg Yolk Antibody (IgY) Against Recombinant Cholera Toxin B Subunit and Evaluation of Its Prophylaxis Potency in Mice.
    Barati B; Ebrahimi F; Nazarian S
    Iran J Immunol; 2018 Mar; 15(1):47-58. PubMed ID: 29549232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin B subunit.
    Matsumoto Y; Suzuki S; Nozoye T; Yamakawa T; Takashima Y; Arakawa T; Tsuji N; Takaiwa F; Hayashi Y
    Transgenic Res; 2009 Apr; 18(2):185-92. PubMed ID: 18763047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the immunogenic potential of plant-expressed cholera toxin B subunit.
    Jani D; Singh NK; Bhattacharya S; Meena LS; Singh Y; Upadhyay SN; Sharma AK; Tyagi AK
    Plant Cell Rep; 2004 Feb; 22(7):471-7. PubMed ID: 14517689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The roles of mesoporous silica and carbon nanoparticles in antigen stability and intensity of immune response against recombinant subunit B of cholera toxin in a rabbit animal model.
    Karimi Bavandpour A; Bakhshi B; Najar-Peerayeh S
    Int J Pharm; 2020 Jan; 573():118868. PubMed ID: 31765785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNAi suppression of rice endogenous storage proteins enhances the production of rice-based Botulinum neutrotoxin type A vaccine.
    Yuki Y; Mejima M; Kurokawa S; Hiroiwa T; Kong IG; Kuroda M; Takahashi Y; Nochi T; Tokuhara D; Kohda T; Kozaki S; Kiyono H
    Vaccine; 2012 Jun; 30(28):4160-6. PubMed ID: 22554467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.
    Talavera A; Año G; García H; Moreira T; Delgado H; Riverón L; Gil S; Miranda A; Cedré B; Valmaseda T; Pino Y; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 May; 24(18):3746-9. PubMed ID: 16085342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal.
    Albert MJ; Alam K; Rahman AS; Huda S; Sack RB
    J Infect Dis; 1994 Mar; 169(3):709-10. PubMed ID: 8158063
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of cholera toxin B subunit in transgenic rice endosperm.
    Oszvald M; Kang TJ; Tomoskozi S; Jenes B; Kim TG; Cha YS; Tamas L; Yang MS
    Mol Biotechnol; 2008 Nov; 40(3):261-8. PubMed ID: 18618297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR.
    Albert MJ; Alam K; Ansaruzzaman M; Qadri F; Sack RB
    J Infect Dis; 1994 Jan; 169(1):230-1. PubMed ID: 8277193
    [No Abstract]   [Full Text] [Related]  

  • 33. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation.
    Borde A; Larsson A; Holmgren J; Nygren E
    Eur J Pharm Biopharm; 2011 Nov; 79(3):508-18. PubMed ID: 21757004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
    Yu X; Ma Q
    Chin J Biotechnol; 1994; 10(4):225-32. PubMed ID: 7780018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermal stability of an oral killed-cholera-whole-cell vaccine containing recombinant B-subunit of cholera toxin.
    Ahmed ZU; Hoque MM; Rahman AS; Sack RB
    Microbiol Immunol; 1994; 38(11):837-42. PubMed ID: 7898381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.
    Hamorsky KT; Kouokam JC; Jurkiewicz JM; Nelson B; Moore LJ; Husk AS; Kajiura H; Fujiyama K; Matoba N
    Sci Rep; 2015 Jan; 5():8003. PubMed ID: 25614217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PaxVax CVD 103-HgR single-dose live oral cholera vaccine.
    Levine MM; Chen WH; Kaper JB; Lock M; Danzig L; Gurwith M
    Expert Rev Vaccines; 2017 Mar; 16(3):197-213. PubMed ID: 28165831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholera as a model for research on mucosal immunity and development of oral vaccines.
    Holmgren J; Czerkinsky C
    Curr Opin Immunol; 1992 Aug; 4(4):387-91. PubMed ID: 1388838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.